Chrome Holding Co.
MEHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $189.9M | $219.6M | $299.5M | $271.9M | $243.9M | $305.5M |
| Operating income | −$240.6M | −$681.5M | −$324.0M | −$254.2M | −$185.2M | −$149,081 |
| Net income | −$280.9M | −$666.7M | −$311.7M | −$217.5M | −$183.6M | −$53,732 |
| Total assets | $159.9M | $395.2M | $942.6M | $1.15B | $452.1M | $509.9M |
| Total liabilities | $186.6M | $206.6M | $228.7M | $236.4M | $210.4M | $17.8M |
| Equity | −$26.7M | $188.5M | $713.9M | $915.7M | −$595.6M | $5.0M |
| EPS (diluted) | $-10.88 | $-28.01 | $-13.80 | — | — | — |
| Shares out. | 25.8M | 476.0M | 451.5M | 361.5M | 99.7M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −126.7%
- Net margin
- −147.9%
- Return on equity
- 1050.4%
- Return on assets
- −175.7%
- Return on capital (ROCE)
- −276.0%
- Liabilities / assets
- 116.7%
- Debt / equity
- —
- Book value / share
- $-1.04
- Revenue growth (YoY)
- −13.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -59.07distress
- Accruals / assets
- −69.6%clean
- Beneish M-Score
- -6.79normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 7, 2025
- NT 10-Qmissed a reporting deadline ↗May 17, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Farallon Capital Partners, L.P.Passive (13G)Jun 20, 2025
- Abeec 2.0, LlcActivist (13D)Jun 16, 2025
- Zentree Investments LtdActivist (13D)Apr 1, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Mar 14, 2025 | 1.8M | 3.2 | +5.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivershipDec 4, 2025
- Other material eventNov 17, 2025
- Regulation FD disclosureNov 4, 2025
- Regulation FD disclosureOct 6, 2025
- Other material eventOct 1, 2025
- Regulation FD disclosureSep 22, 2025
- Entered a material agreementSep 11, 2025
- Director / officer changeAug 22, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GDec 4, 2025
- 8-KDec 4, 2025
- 8-KNov 17, 2025
- NT 10-QNov 7, 2025
- 8-KNov 4, 2025
- 8-KOct 6, 2025
- 8-KFORM 8-KOct 1, 2025
- 8-KSep 22, 2025
- 8-KFORM 8-KSep 11, 2025
- 8-KAug 22, 2025
- 4FORM 4Aug 21, 2025
- 8-KAug 18, 2025
- 8-KFORM 8-KAug 15, 2025
- 10-QAug 4, 2025
- 10-K/AJul 25, 2025